SD

Sachendra Dubey

Active Director Director DIN 10171843
DIN 10171843 First appointment May 2023 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2023
Shareholding value •••• Premium profile

About Sachendra Dubey

Data last updated:

Sachendra Dubey is a Director at Curasis Lifesciences Private Limited (since 2023). The company operates in Pharma. Curasis Lifesciences Private Limited reported revenue of ₹21.3 Lakh (FY 2025).

DIN 10171843
Primary Designation Director
Industry Pharma
First Appointment 22 May 2023
Oldest Company Age 3 yrs
Largest company Curasis Lifesciences Private Limited · ₹21.3 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Curasis Lifesciences Private Limited U46497MP2023PTC065877
Director22 May 20232023₹21.3 Lakh (FY 2025)Active

Board colleagues of Sachendra Dubey

NameDINCompanyDesignation
Rajeev Singh Singroul10171844Curasis Lifesciences Private LimitedDirector

Directorship timeline

Open interactive timeline →
Curasis Lifesciences Private Limited
Premium access

Shareholding and investment profile for Sachendra Dubey

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sachendra Dubey

Sachendra Dubey currently holds 1 directorship: Curasis Lifesciences Private Limited (Director, since 22 May 2023, revenue ₹21.3 Lakh (FY 2025)).

Sachendra Dubey was first appointed on 22 May 2023 as Director at Curasis Lifesciences Private Limited.

The current boards of Sachendra Dubey's companies include Rajeev Singh Singroul (Curasis Lifesciences Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available